“…Correction of anemia with recombinant human erythropoietin (rHuEPO) has been reported to improve nutritional status to a moderate degree in HD patients (68). Positive effects (that is, increased body weight, serum albumin, and total protein, as well as improvement in appetite, sleep, and wellbeing, by patients' self-assessment) were also recently reported in a small retrospective study of 17 CAPD patients that started treatment with rHuEPO (69).…”